[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.108.182. Please contact the publisher to request reinstatement.
[Skip to Navigation Landing]
Views 199
Citations 0
Observation
September 2018

Pleomorphic Adenoma of the Nasolacrimal Duct

Author Affiliations
  • 1Division of Otolaryngology–Head & Neck Surgery, Department of Surgery, University of California San Diego, San Diego
  • 2Department of Pathology, University of California San Diego, San Diego
  • 3Division of Ophthalmic Plastic and Reconstructive Surgery, Department of Ophthalmology, University of California San Diego, La Jolla
  • 4Division of Plastic Surgery, Department of Surgery, University of California San Diego, San Diego
JAMA Otolaryngol Head Neck Surg. 2018;144(9):849-851. doi:10.1001/jamaoto.2018.1448

Nasolacrimal system tumors are rare, typically presenting to ophthalmologists given that epiphora is the most common initial symptom.1 Although these tumors have historically been treated by ophthalmologists via the open approach, in recent years, otolaryngologists have played an increasingly important role given the visual and technical advantages of endoscopic sinus surgery.

×